CHMP endorses review finding no link between viral vector in Zynteglo and blood cancer

View source ↗

Summary

The CHMP endorses a review finding that there is no link between the viral vector used in Zynteglo and the development of blood cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta-thalassemia
• Sickle Cell Disease

Drugs mentioned

• Zynteglo (luspogene nepogene)